Oneness Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3,305	1,659	1,048	812.83	5,655	332.96
Short-Term Investments	2,068	4,165	5,971	6,960	2,392	7,473
Cash & Short-Term Investments	5,373	5,823	7,019	7,773	8,047	7,806
Cash Growth	-20.54%	-17.03%	-9.70%	-3.40%	3.08%	-6.14%
Accounts Receivable	52.75	46.81	18.34	25.77	13.08	14.59
Other Receivables	157.14	95.83	77.88	50.77	19.86	114.2
Receivables	209.89	142.64	96.22	76.54	32.95	128.79
Inventory	107.62	108.89	115.16	122.74	111.4	81.32
Other Current Assets	40.45	83.16	62.83	45.93	42.2	35.31
Total Current Assets	5,731	6,158	7,293	8,018	8,233	8,051
Property, Plant & Equipment	969.11	994.89	1,106	1,195	1,033	1,038
Long-Term Investments	2,978	3,146	3,737	4,096	3,920	3,871
Goodwill	-	57.44	57.44	89.14	89.14	89.14
Other Intangible Assets	941.92	933.83	1,125	1,682	2,010	2,388
Long-Term Accounts Receivable	-	11.42	-	-	-	32.41
Long-Term Deferred Tax Assets	237.25	238.82	137.57	79.21	97.46	62.85
Other Long-Term Assets	202.51	192.92	204.05	204.05	197.65	197.86
Total Assets	11,060	11,734	13,660	15,364	15,580	15,731
Accounts Payable	5.41	3.6	2.73	1.7	1.52	2.5
Accrued Expenses	-	415.18	103.57	119.05	155.39	78.16
Current Portion of Leases	44.25	42.96	41.18	34.25	13.25	12.73
Current Income Taxes Payable	0.05	0.87	0.12	0.12	12.69	35.1
Other Current Liabilities	101.55	58.8	35.32	60.24	25.76	28.75
Total Current Liabilities	151.26	521.42	182.92	215.36	208.6	157.24
Long-Term Leases	317.34	327.77	365.18	397.95	250.09	270.34
Long-Term Unearned Revenue	169.38	169.52	170.68	176.07	145.99	1,155
Long-Term Deferred Tax Liabilities	237.97	237.26	140.41	76.56	95.22	58.18
Other Long-Term Liabilities	0.47	0.47	0.47	0.48	0.48	0.48
Total Liabilities	876.42	1,256	859.65	866.43	700.38	1,642
Common Stock	4,804	4,802	4,791	4,545	3,910	3,853
Additional Paid-In Capital	6,526	6,515	7,623	9,050	8,637	9,469
Retained Earnings	-1,189	-1,038	-1,154	-1,267	359.98	-1,036
Treasury Stock	-25.78	-25.78	-25.78	-25.78	-25.78	-47.38
Comprehensive Income & Other	-77.48	78.11	1,066	1,750	1,737	1,778
Total Common Equity	10,037	10,332	12,299	14,053	14,618	14,016
Minority Interest	146.2	145.45	501.02	444.07	262.28	72.95
Shareholders' Equity	10,184	10,477	12,800	14,497	14,880	14,089
Total Liabilities & Equity	11,060	11,734	13,660	15,364	15,580	15,731
Total Debt	361.59	370.73	406.35	432.2	263.34	283.07
Net Cash (Debt)	5,012	5,453	6,613	7,341	7,783	7,523
Net Cash Growth	-21.28%	-17.54%	-9.92%	-5.69%	3.46%	-6.13%
Net Cash Per Share	10.46	11.37	13.83	15.50	16.50	16.52
Filing Date Shares Outstanding	479.21	479.21	478.03	476.23	466.02	458.4
Total Common Shares Outstanding	479.21	479.21	478.03	476.23	466.02	458.4
Working Capital	5,580	5,637	7,110	7,803	8,025	7,894
Book Value Per Share	20.95	21.56	25.73	29.51	31.37	30.58
Tangible Book Value	9,096	9,340	11,117	12,282	12,519	11,539
Tangible Book Value Per Share	18.98	19.49	23.26	25.79	26.86	25.17
Buildings	-	640.6	640.27	637.35	602.54	580.99
Machinery	-	555.57	554.04	547.55	522.99	456.01
Construction In Progress	-	18.76	1.98	18.24	-	13.03
Leasehold Improvements	-	61.91	58.15	27.56	14.56	14.01